Figure 11A–D shows that there was variability in the stromal, immune, and estimated scores of patients with HCC, indicating some differences in the TME according to the level of IGF1, CDKN2A, BIRC5, and SPP1. The gene discussed is IGF1; the disease is hepatocellular carcinoma.